Pfizer–BioNTech COVID-19 vaccine
| Pfizer–BioNTech COVID-19 vaccine |
|Interest of||Byram Bridle|
The Pfizer–BioNTech COVID-19 vaccine tozinameran), sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech in collaboration with Pfizer. As of 30 March 2021, Pfizer and BioNTech aimed to manufacture about 2.5 billion doses in 2021.
|Pfizer Scientists: ‘Your [COVID] Antibodies Are Better Than The [Pfizer] Vaccination. / Project Veritas|
On November 18th Pfizer and BioNTech announced they had concluded their phase three trial of BNT. They had demonstrated efficacy of 95% making it possible to give it an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration. 
However, this 95% figure was based upon relative risk reduction. That is the declared percentage difference between the vaccinated group’s 8/18310 chance (0.044%) of developing COVID 19 against a 162/18319 (0.88%) chance of COVID 19 symptoms without the vaccine. It should be noted this only refers to an alleged reduction of COVID 19 symptoms among those who have the virus. The tested endpoints do not demonstrate that the vaccine will either reduce the spread of infection or save lives. It should also be noted that these figures suggest the threat from COVID 19 is vanishingly small.
Media outlets, politicians, and public health officials have blared the 95% efficacy. To the casual observer, this would denote 95% reduction in hospitalizations or deaths. When in fact the 95% is calculated, based upon the “Primary Efficacy Endpoints.” In the trial literature these endpoints are described by both companies as non-severe cold/flu symptoms coupled with a positive PCR.
In absolute terms, the effectiveness of the vaccine is (0.88-0.044)% - a risk reduction of 0.84%. In all, this means that according to the preliminary Pfizer-results, someone who takes the Pfizer/BioNtech injection has less than 1% chance of reducing at least one symptom of non-severe “Covid” for a period of 2 months.
In the trials, approximately 5-6 symptoms listed as “side effects” are the same as Covid symptoms. To further bias the trial, Pfizer/BioNtech only started counting “cases” one week after the second dose, and Moderna, 2 weeks after the second dose. Therefore, if these side effects were labelled as “Covid” symptoms instead, even the paltry efficacy of about 1% would be relegated into the negative integers. In others words, the injected group may have been sicker with “Covid” more than the placebo group.
In all, the trials seem to have been a formality for a possibly already existing product using a number of novel technologies with unknown effects.
The actual product is a trade secret, but a Pfizer injection contains maybe 14.400 trillion synthetic spike proteins wrapped in lipid nanoparticles. The nanoparticles might be able to carry 8 mRNA proteins each. The nanoparticles are made up of the widely used pharmaceutical ingredient polyethylene glycol (PEG). This is the first time they are used in an injection.
The lipid shell plays a triple role. First, it protects the genetic material from degradation prior to cellular uptake. Second, the lipid shell, which also contains cholesterol, facilitates cellular uptake through fusion with the lipid membrane of the cell. And finally, it acts as an adjuvant.
A 2019 study showed that small doses of PEG can lead to dramatic pathological immune activation. Animal studies has shown that it is responsible for both anaphylaxis and cardiovascular collapse, and injected PEG activates multiple allergic reactions in humans as well.
In the clinical phase the RNA, was produced with completely different techniques to how it is being mass produced. During the clinical phase they only needed small volumes of vaccine, they were able to use very expensive techniques that delivered highly purified end products. Now that they have entered mass production, that is no longer possible, they have had to switch to lower-cost processes, e.g. using huge quantities of DNA that functions as the substrate to be able to produce the RNA in an in-vitro transcription reaction….
Thorough evaluation means continue to collect data
On 21 December 2020, following approval by the UK's MHRA and the US FDA, the European Medicines Agency (EMA) authorised the Pfizer BioNTech Covid-19 vaccine for the EU's nearly 448 million inhabitants. The EMA said the drug had demonstrated an efficacy of 95% and could be used in people aged 16 and over:
- "Today's positive news is an important step forward in our fight against this pandemic, which has caused suffering and hardship for so many," said the EMA's executive director, Emer Cooke. "Our thorough evaluation means that we can confidently assure EU citizens of the safety and efficacy of this vaccine and that it meets necessary quality standards. However, our work does not stop here. We will continue to collect and analyse data on the safety and effectiveness of this vaccine to protect people taking the vaccine in the EU."
On 26th of July 2021, the cybersecurity researcher Ehden Biber started to publish the contract Pfizer has with Brazil and Albania online, using the hashtag #PfizerLeak on Twitter. The exposure was quickly censored by Twitter.
- As part of the sale, Pfizer made the governments explicitly acknowledge that long-term effects are still not known: “Purchaser further acknowledges that the long-term effects and efficacy of the Vaccine are not currently known and that there may be adverse effects of the Vaccine that are currently not known.”
- Pfizer asked for additional indemnity from civil cases, meaning that the company would not be held liable for rare adverse effects or for its own acts of negligence, fraud or malice. This includes those linked to company practices – for example, if Pfizer sent the wrong vaccine or made errors during manufacturing.
- The corporation asked the countries to put up sovereign assets, such as embassy buildings and military bases, as a guarantee against the cost of any future legal cases.
In September 2021, Pfizer announced a COVID pill that is meant to be taken alongside the COVID vaccine. Pfizer is so confident that the pill will be swiftly approved and mandated by governments that it has already started manufacturing at scale at the same time as it started a phase 2/3 study.
Pfizer CEO Albert Bourla instantly cashed in on the announcement, selling 60 percent of his Pfizer stock at $41.99, its highest level in more than a year.  The sale had been arranged in advance under a so-called Rule 10b5-1 trading plan, which allows corporate executives to make predetermined stock transactions in compliance with insider trading laws. Bourla adopted the trading plan in August of this year.
Sally Susman, the company’s executive vice president and chief corporate affairs officer, dumped more than 43,000 shares to the tune of about $1.8 million.  The sale was allegedly made under a Rule 10b5-1 plan Susman adopted in November 2019.
|Albert Bourla||“The dynamics in the COVID more and more indicate a potential that we will have a clearly repeated business… Now we still don’t have data about the immunity of our vaccine because it is early. But we do see that the people that have the disease, more and more publications indicate that after several months, the immune response goes down. So there is a need to boost.””||Albert Bourla|
|Byram Bridle||“But this is because these COVID-19 vaccines have reached the public rollout phase by, and I’ll say it in quotes, “cutting corners”. And by cutting corners, I’m not implying that people were skipping key steps, although honestly, there could be some potential questions around that.”||Byram Bridle||24 February 2021|
|Byram Bridle||“None of us were expecting, I don’t think, that the vaccines would be rolled out very early on in the phase three clinical trials. So the phase three trials are not done. So in essence, what this means is the public rollout right now is an extension of the phase three clinical trial. So those being vaccinated now are, whether they realize it or not, part of the phase three experiment.”||Byram Bridle||24 February 2021|
|Byram Bridle||“We made a big mistake. We didn’t realize it until now...We thought the spike protein was a great target antigen...So by vaccinating people we are inadvertently inoculating them with a toxin....We have known for a long time that the spike protein is a pathogenic protein. It is a toxin. It can cause damage in our body if it gets into circulation...Now, we have clear-cut evidence that the vaccines that make the cells in our deltoid muscles manufacture this protein — that the vaccine itself, plus the protein — gets into blood circulation”||Byram Bridle||24 February 2021|
|COVID-19/Vaccine||“Two months is not enough time to know that we won’t have that antibody enhancement problem,” Merritt said. “And I will make this military point: It’s the perfect binary weapon. There’s no way I know exactly what that mRNA is programmed to do and neither do you and neither do most doctors. The doctors can’t get that data. That rests with the guys at the very top of this project. They say it’s to the spiked protein but how do we prove it?
.So if I were China and I wanted to take down our military, that’s easy,” she continued. “I could hook onto this coronavirus, like the spiked protein or another protein, I just design an mRNA to do that, but I know it doesn’t exist in nature so nobody is going to die from the vaccine, and then two years later I release whatever it is I made, the counterpart, and it causes this immunity enhancement death. So it’s a time-delayed death. That’s what binary poisons are: I give you point one, and then later on you accidentally come in contact with point two and you die.”
|Dr. Lee Merritt||January 2021|
|Dolores Cahill||“Anyone who’s over 70 who gets one of these mRNA vaccines will probably sadly die within about two to three years. And I would say anyone who gets the mRNA injection, no matter what age you are, your life expectancy will be reduced to, you know, die if you’re in your thirties within five to ten years, and you probably will have allergy, neuro-cognitive issues, inflammation, and of course infertility is the major one”||Dolores Cahill||May 2021|
|Michael Yeadon||“The toxicity of 1st generation vaccines is incidental & presumably is because they REQUIRE this gene based technology to execute their plans.”||Michael Yeadon||August 2021|
|Document:Why are government experts holding off vaccinating under-16s in the UK?||Article||6 August 2021||Deepti Gurdasani||Pro COVID-19/Vaccine propaganda from an epidemiologist with ties to Big Pharma. The JCVI does not recommend jabs for under-16s and the approval process has slowed down. The rushed vaccination process is not rushed enough apparently.|
- "Covid: Pfizer-BioNTech vaccine approved for EU states"
- https://senseofawareness.com/2021/07/29/pfizerleak-exposing-the-pfizer-manufacturing-and-supply-agreement-day-12/ saved at Archive.org saved at Archive.is